RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17+ pathological differentiation
The Th17+ arrangement is critical for orchestrating both innate and acquired immune responses. In this context, the serum and glucocorticoid regulated kinase 1 (SGK1) exerts a key role in the governance of IL-23R-dependent Th17+ maturation, through the phosphorylation-dependent control of FOXO1 loca...
Main Authors: | Carolina Brescia, Vincenzo Dattilo, Lucia D’Antona, Emanuela Chiarella, Rossana Tallerico, Salvatore Audia, Valentina Rocca, Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Rosario Amato |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1213805/full |
Similar Items
-
RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases
by: Salvatore Audia, et al.
Published: (2023-01-01) -
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence
by: Rosario Amato, et al.
Published: (2022-06-01) -
Kinase Inhibitors in Genetic Diseases
by: Lucia D’Antona, et al.
Published: (2023-03-01) -
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy
by: Francesco Paduano, et al.
Published: (2022-07-01) -
SGK1 in Cancer: Biomarker and Drug Target
by: Jonas Cicenas, et al.
Published: (2022-05-01)